Chemed (CHE) Stock: Buy, Sell, or Hold?
CHE - Chemed Corporation
$507.50
4.60 (0.91%)
▲
5d:
-0.91%
30d:
-3.15%
90d:
+5.62%
HOLD
MODERATE Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Oct 27, 2026
23d
Get Alerted When CHE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CHE is fairly valued with market pricing in 2.5% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: CHE is fairly valued with market pricing in 2.5% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$627.96
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$389.91
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CHE is currently trading at $507.50, which is considered slightly low relative to its 30-day fair value range of $501.83 to $526.10. The stock's valuation (Forward PE: 18.4) is in line with its historical norms (17.1). At these levels, the market is pricing in 2.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CHE is in a strong uptrend. The price is approaching resistance at $519.04. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $571.60 (+12.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CHE is in a strong uptrend. The price is approaching resistance at $519.04. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $571.60 (+12.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$501.83 -
$526.10
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (54/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($571.60)
- NEUTRAL: Market pricing in 2.5% annual earnings growth - fairly valued
- NEUTRAL: Bottoming setup forming (54/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$501.83 -
$526.10
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$491.88
Resistance Level
$519.05
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.44
Wall Street Target
$571.60
(+12.6%)
Revenue Growth (YoY)
8.8%
Earnings Growth (YoY)
43.7%
Profit Margin
10.6%
Valuation Premium vs History
+2.5% premium
PE vs Historical
18.4 vs 17.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.5%
(market-implied from PE analysis)
1-Year Target
$520.19
(+3%)
2-Year Target
$533.19
(+5%)
3-Year Target
$546.52
(+8%)
3-Yr Target (if PE normalizes)
(PE: 18→17)
PE COMPRESSION
$506.74
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 7.9%)
$705.97
(+39%)
Base:
(SPY PE: 18.4, Growth: 7.9%)
$638.23
(+26%)
Bear:
(PE: 15.7, Growth: 7.9%)
$542.50
(+7%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 25.27 | Current EPS (TTM): $19.90
Bull Case
$764.96
(+51%)
Analyst growth 38.3%, PE expands to 27.8
Base Case
$695.42
(+37%)
Market implied 38.3%, PE stable at 25.3
Bear Case
$341.97
(-33%)
Severe decline -20.0%, PE contracts to 21.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 03, 2026 12:10 PM ET
Data refreshes hourly during market hours. Next update: 1:10 PM
Data refreshes hourly during market hours. Next update: 1:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CHE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 61 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$454 | 48 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 55 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$134 | 67 BUY |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 62 BUY |